SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PLC Systems -- Ignore unavailable to you. Want to Upgrade?

To: Larry Southam who wrote (619)4/21/1998 6:01:00 PM
From: GRC  Read Replies (1) | Respond to of 1202
 
I sold all the stock I purchased under 12, and bought puts at 17.5, calls at 20. If options expire worthless I'm still ahead on the stock proceeds. On the other hand, I come out ahead on the options below about 12.5 or above about 25. I just can't see the price not falling below 12.5 on non-approval, or above 25 on approval. I'm considering more options, any opinions would be appreciated.

GRC



To: Larry Southam who wrote (619)4/21/1998 6:09:00 PM
From: John F. Dowd  Respond to of 1202
 
Thanks for the info Larry. Seems like an article written on a speculative opinion rather than on the merits - to wit most recent press releases. But the FDA has done stranger things.

Thanks again,

JFD



To: Larry Southam who wrote (619)4/21/1998 11:31:00 PM
From: Mike Sesan  Respond to of 1202
 
FY INFO.

FDA Panel phone number 1-800-741-8138 - panel number 12625 for details of Friday's Meeting.

Mike


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News